sCR1sLeX reduces lung allograft ischemia–reperfusion injury but does not ameliorate acute rejection

Uz Stammberger

doi:10.1016/s1010-7940(02)00355-x

ScienceGate Book Chapters

JOURNAL ARTICLE

sCR1sLeX reduces lung allograft ischemia–reperfusion injury but does not ameliorate acute rejection

Uz Stammberger

Year: 2002 Journal: European Journal of Cardio-Thoracic Surgery Vol: 22 (3)Pages: 368-372 Publisher: Oxford University Press

DOI: 10.1016/s1010-7940(02)00355-x

Get Full-Text PDF Get Analytical Report

Abstract

In this model sCR1sLe(X) provided marked improvement of graft function up to 3 days, but inhibition of both complement system and selectin dependent leukocyte adhesion failed to protect against acute rejection.

Keywords:

Medicine Lung transplantation Lung Transplantation Urology Reperfusion injury Ischemia Surgery Anesthesia Internal medicine

Metrics

Cited By

0.62

FWCI (Field Weighted Citation Impact)

Refs

0.71

Citation Normalized Percentile

Is in top 1%

Is in top 10%

Citation History

Topics

Transplantation: Methods and Outcomes

Health Sciences → Medicine → Surgery

Complement system in diseases

Life Sciences → Immunology and Microbiology → Immunology

Renal Transplantation Outcomes and Treatments

Health Sciences → Medicine → Transplantation

sCR1sLeX reduces lung allograft ischemia–reperfusion injury but does not ameliorate acute rejection

Abstract

Metrics

Citation History

Topics

Related Documents

sCR1sLeX reduces lung allograft ischemia–reperfusion injury but does not ameliorate acute rejection

sCR1sLeX ameliorates ischemia/reperfusion injury in experimental lung transplantation

Pentoxifylline Reduces Lung Allograft Reperfusion Injury

Pentoxifylline reduces lung allograft reperfusion injury

Enoxaparin Does Not Ameliorate Limb Ischemia-Reperfusion Injury